Sree Rayalaseema Hi-Strength Hypo sets Sep 26 AGM, recommends ₹3 dividend
- Sree Rayalaseema Hi-Strength Hypo sets 21st AGM for September 26, 2026
- Board recommends final dividend of ₹3 per equity share for FY26
- Standalone turnover rose 4.57% YoY to ₹666.96 crore in FY26
- Shareholders to approve ₹425 crore related party transactions with TGV SRAAC Ltd
- Kasturi Phaneendra Rao seeks appointment as Independent Director

*this image is generated using AI for illustrative purposes only.
Sree Rayalaseema Hi-Strength Hypo has scheduled its 21st Annual General Meeting for Saturday, September 26, 2026 at 4:00 pm via video conference. The meeting coincides with the release of its Annual Report for the financial year ended March 31, 2026.
The AGM notice, filed with BSE Limited and the National Stock Exchange of India Limited on August 12, 2026, was submitted pursuant to Regulation 34(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The registered office at Gondiparla, Kurnool will serve as the deemed venue for the meeting.
Financial Performance for FY 2025-26
The company reported a standalone turnover of ₹666.96 crore for FY26, compared to ₹637.82 crore in the previous year. Standalone profit before tax stood at ₹123.29 crore, against ₹124.36 crore in the prior year. The following table summarises the key standalone and consolidated financial highlights:
| Particulars | Standalone FY26 (₹ in lakhs) | Standalone FY25 (₹ in lakhs) | Consolidated FY26 (₹ in lakhs) | Consolidated FY25 (₹ in lakhs) |
|---|---|---|---|---|
| Profit before interest, depreciation and tax | 13,058.30 | 13,203.25 | 12,969.90 | 12,844.81 |
| Less: Interest | 167.78 | 197.87 | 167.27 | 197.89 |
| Less: Depreciation | 561.74 | 569.56 | 723.89 | 731.71 |
| Profit before tax | 12,328.78 | 12,435.82 | 12,078.23 | 11,915.21 |
| Provision for taxation and deferred income tax | 3063.71 | 3,168.31 | 3063.71 | 3,168.31 |
| Profit after tax | 9265.07 | 9,267.51 | 9014.52 | 8,746.90 |
Segment-Wise Performance
The company's key product segments showed mixed performance during FY26:
- Calcium Hypochloride: Net sales of ₹288.45 crore against ₹320.59 crore in the previous year, a decrease of 10.03%
- Stable Bleaching Powder: Net sales of ₹73.75 crore against ₹71.24 crore, an increase of 3.52%
- Sodium Methoxide: Net sales of ₹24.68 crore against ₹40.25 crore, a decrease of 38.67%
- Sodium Hydride: Net sales of ₹2.87 crore against ₹1.60 crore, an increase of 79.49%
- Sulphuric Acid: Net sales of ₹253.36 crore against ₹173.79 crore, an increase of 45.78%
- Wind and Solar Power: Total power generated and sold during the year was ₹7.31 crore
Dividend and Record Date
The Board of Directors has recommended a final dividend of ₹3 per equity share of face value ₹10 each (30% on paid-up share capital), amounting to ₹5,14,94,463 for FY26, subject to shareholder approval at the AGM. The record date for determining dividend entitlement is Friday, September 18, 2026. If approved, the dividend will be paid on or before October 23, 2026.
AGM Business Items
The following items are scheduled for consideration at the 21st AGM:
Ordinary Business:
- Adoption of audited standalone and consolidated financial statements for FY26
- Declaration of final dividend of ₹3.00 per equity share for FY26
- Re-appointment of H. Gurunath Reddy (DIN: 07211326), who retires by rotation
Special Business:
- Ratification of remuneration of ₹90,000 plus applicable taxes payable to Thota SSV Santhosh Kumar as Cost Auditor for the financial year ending March 31, 2027
- Appointment of Kasturi Phaneendra Rao (DIN: 11881707) as Independent Director for a first term of five consecutive years effective August 12, 2026 to August 11, 2031
- Approval of material related party transactions with TGV SRAAC Limited up to ₹425 crore for FY27
Related Party Transaction with TGV SRAAC Limited
Shareholders are being asked to approve material related party transactions with TGV SRAAC Limited, a promoter group entity. The proposed transaction value for FY27 is ₹425 crore, covering purchases, sales, lease rentals, and other services. The actual transactions in FY26 totalled ₹104.46 crore. The proposed value represents 63.72% of the company's audited consolidated annual turnover of ₹666.96 crore for FY26.
| Transaction Type | FY26 Actuals (₹ crore) | FY27 Estimated (₹ crore) |
|---|---|---|
| Purchases | 74.08 | 200.00 |
| Sales | 21.78 | 200.00 |
| Lease Rentals (paid) | 0.07 | 0.30 |
| Lease Rentals (received) | 0.16 | 0.70 |
| Sale of Land | 3.31 | — |
| Sale of Solar Power Plant | 5.06 | — |
| Others | — | 24.00 |
| Total | 104.46 | 425.00 |
E-Voting and Meeting Details
The remote e-voting period opens on September 23, 2026 at 9:00 am and closes on September 25, 2026 at 5:00 pm. The cut-off date for determining voting rights is September 18, 2026. CDSL has been appointed as the e-voting agency. MNM & Associates, Practicing Company Secretary, has been appointed as Scrutinizer. The company's paid-up equity share capital as on March 31, 2026 stands at ₹17,16,48,210, comprising 1,71,64,821 equity shares of ₹10 each.
Historical Stock Returns for Sree Rayalaseema Hi-Strength Hypo
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +3.11% | +18.84% | +28.02% | +46.02% | +0.02% | +77.69% |
How will the significant 307% increase in the related party transaction limit with TGV SRAAC Limited to ₹425 crore impact shareholder confidence and potential regulatory scrutiny?
What strategic initiatives is Sree Rayalaseema pursuing to offset the 10% decline in its core Calcium Hypochloride segment sales?
Given the 45.78% surge in Sulphuric Acid sales, does this indicate a successful product mix diversification or a temporary market anomaly?
































